Loading market dashboard
NexgenRx Inc.
NEGXFHealthcareOTCCA
Loading disclosure news
News and disclosures filtered by period, publisher, and event group.
Select a headline to open the full news page in the app.
TORONTO, ON / ACCESS Newswire / May 21, 2026 / NEXGENRX INC. ("NexgenRx" or the "Company") is pleased to announce its financial results for the first quarter ended March 31, 2026, with net income of $1,228,288 and EBITDA of $1,444,036, representing increases of $701,078 and $615,635, respectively, compared to the same period in 2025.
TORONTO, ON / ACCESS Newswire / April 17, 2026 / NEXGENRX INC. ("NexgenRx" or the "Company") is pleased to announce that a dividend in the amount of one-half of one cent per share ($0.005) has been declared in respect of all of its outstanding common shares.
TORONTO, ON / ACCESS Newswire / March 31, 2026 / NEXGENRX INC. ("NexgenRx" or the "Company") is pleased to announce its annual financial results for the financial year ended December 31, 2025, with net income and EBITDA improving to $3,350,704 (an increase of $1,011,282 as compared to 2024), net income increasing to $1,289,735 (an increase of $675,166 as compared to 2024) and revenues increasing by $1,457,136, to $14,933,914.
